PROXY2002

Company

Ernexa Therapeutics Inc.

Filed

April 17, 2002

Period of Report

April 1, 2002

Accession Number

0000748592-02-000007

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →